Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD Chief Financial Officer | September 14, 2022 | September 19, 2022 |
| Marex Group LtdMRX · Entity 9106 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 14, 2022 · Filed September 19, 2022 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 51,867 |
Reported balance
After 2022-09-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2022-09-14 · Tax withholding · Disposed 446 · Balance 51,867 F1: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022.
F2: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error.
Marex Group Ltd
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 23,771 |
Reported balance
After 2026-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 2,070 · Balance 23,771 F1: The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,740 | $186.90 | $325,201.13 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 13,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.04 to $186.99 and $187.00 to $187.69. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 1,740 | $62.83 | $109,324.20 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 12,060 | $186.90 | $2,253,980.23 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 13,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.04 to $186.99 and $187.00 to $187.69. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 12,060 | $54.30 | $654,858.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 18:33 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $179.86 | $449,650.00 |
DisclosureSEC source: 0001156375-18-000121 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:10 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 315 | $173.15 | $54,542.25 |
DisclosureSEC source: 0001156375-18-000092 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,220 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:10 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 604 | $173.15 | $104,582.60 |
DisclosureSEC source: 0001156375-18-000092 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,535 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:10 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 624 | $173.15 | $108,045.60 |
DisclosureSEC source: 0001156375-18-000092 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,139 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:10 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 458 | $173.15 | $79,302.70 |
DisclosureSEC source: 0001156375-18-000092 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,763 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:10 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000092 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,221 Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 18:59 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $164.11 | $410,275.00 |
DisclosureSEC source: 0001156375-18-000075 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,457 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On July 10, 2018, Mr. Pietrowicz sold an aggregate of 2,500 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $163.32 to $163.62 and $164.02 to $164.66. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 21:16 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $161.02 | $402,550.00 |
DisclosureSEC source: 0001156375-18-000041 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,957 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| March 16, 2018 Filed Mar 19, 2018 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 132 | $165.12 | $21,795.84 |
DisclosureSEC source: 0001156375-18-000036 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,457 F4 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/18. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,337 | $165.66 | $387,147.42 |
DisclosureSEC source: 0001156375-18-000036 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,589 F3 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,107 | $165.66 | $183,385.62 |
DisclosureSEC source: 0001156375-18-000036 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,926 F3 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:31 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000036 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,033 F2 · shares: Represents shares earned from a 2014 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2015-2017. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:31 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000036 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,873 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2015-2017. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 16:23 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 7,500 | $151.50 | $1,136,250.00 |
DisclosureSEC source: 0001156375-18-000002 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,376 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 20:05 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,175 | $0.00 Strike: $83.88 | $0.00 |
DisclosureSEC source: 0001156375-17-000109 · edgardoc.xml · derivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 5,175 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 16, 2013, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 20:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 5,175 | $139.70 | $722,934.56 |
DisclosureSEC source: 0001156375-17-000109 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,876 Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 20:05 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 5,175 | $83.88 | $434,079.00 |
DisclosureSEC source: 0001156375-17-000109 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2017 Filed Oct 12, 2017 21:25 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $136.83 | $342,075.00 |
DisclosureSEC source: 0001156375-17-000105 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,876 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| September 16, 2017 Filed Sep 19, 2017 18:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 298 | $131.29 | $39,124.42 |
DisclosureSEC source: 0001156375-17-000097 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,376 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,533 | $131.29 | $201,267.57 |
DisclosureSEC source: 0001156375-17-000097 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,674 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:38 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 5,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000097 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,207 Read SEC document |
| July 10, 2017 Filed Jul 10, 2017 21:26 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $124.50 | $311,250.00 |
DisclosureSEC source: 0001156375-17-000077 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,495 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| April 10, 2017 Filed Apr 10, 2017 20:27 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $117.85 | $294,625.00 |
DisclosureSEC source: 0001156375-17-000038 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,995 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 22:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 140 | $124.74 | $17,463.60 |
DisclosureSEC source: 0001156375-17-000032 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,495 F3 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/2017. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000032 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,635 F2 · shares: Represents shares earned from a 2013 performance share award based upon the company's achievement of cash earnings per share growth and total shareholder return relative to the S&P 500 measured over 2014-2016. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,134 | $124.74 | $266,195.16 |
DisclosureSEC source: 0001156375-17-000032 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,535 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 7,500 | $116.77 | $875,775.00 |
DisclosureSEC source: 0001156375-17-000005 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,669 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 22:13 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,625 | $0.00 Strike: $110.54 | $0.00 |
DisclosureSEC source: 0001156375-16-000262 · edgardoc.xml · derivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 4,625 shares Expires 2017-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 22:13 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,625 | $123.30 | $570,277.30 |
DisclosureSEC source: 0001156375-16-000262 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,169 F1 · price: On December 12, 2016, Mr. Pietrowicz sold an aggregate of 4,625 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.30 to $123.33. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 22:13 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 4,625 | $110.54 | $511,247.50 |
DisclosureSEC source: 0001156375-16-000262 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 20:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 297 | $109.65 | $32,566.05 |
DisclosureSEC source: 0001156375-16-000234 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,169 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2016. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:39 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 856 | $109.28 | $93,543.68 |
DisclosureSEC source: 0001156375-16-000220 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,290 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2016. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 20:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-16-000234 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,466 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:39 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 347 | $107.55 | $37,319.85 |
DisclosureSEC source: 0001156375-16-000220 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,146 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.